KLAYESTA (nystatin)

There are 0 contraindications.

There are 0 severe contraindications.

There are 1 moderate contraindications. Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.

Moderate List
No disease contraindications

There are 0 severe adverse reactions.

There are 5 less severe adverse reactions.

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Eczema Pruritus of skin Skin irritation Skin rash Treatment site sequelae

Animal reproduction studies have not been performed using topical or oral nystatin. It is not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Topical nystatin should be used during pregnancy only if potential benefits outweigh potential risks to the fetus.

Oral nystatin (oral suspension, tablets) should be used during pregnancy only if clearly needed. Fixed-combination topical preparations containing nystatin and triamcinolone acetonide should be used during pregnancy only if potential benefits outweigh potential risks to the fetus. Topical preparations containing corticosteroids should not be used extensively, in large amounts, or for prolonged periods during pregnancy.

It is not known whether nystatin is distributed into human milk. Nystatin and fixed combinations containing nystatin and triamcinolone acetonide should be used with caution in nursing women.

No enhanced Geriatric Use information available for this drug.